ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2,1,Ovarian hyperstimulation syndrome,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
2,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
4,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
5,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
6,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
7,1,Ovarian hyperstimulation syndrome,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
8,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
9,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
9,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
9,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
10,1,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
10,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11,1,Ovarian hyperstimulation syndrome,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
12,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
12,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
12,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
12,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
13,1,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
14,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
14,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
15,1,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
15,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
16,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
17,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
18,1,Headache,Headaches NEC,Headaches,Nerv,N
18,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
18,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
20,1,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
21,1,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
22,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
22,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
24,1,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
25,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
26,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
26,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
26,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
26,6,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,7,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
27,1,Hypomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
28,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
29,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
30,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
30,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
32,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
33,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
34,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
34,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
35,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
36,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
37,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
38,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
38,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
39,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
39,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
